estrone has been researched along with Cancer of Endometrium in 42 studies
Hydroxyestrones: Estrone derivatives substituted with one or more hydroxyl groups in any position. They are important metabolites of estrone and other estrogens.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although endometrial cancer is clearly influenced by hormonal factors, few epidemiologic studies have investigated the role of endogenous estrogens or especially estrogen metabolites." | 1.43 | Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. ( Anderson, GL; Brinton, LA; Falk, RT; Felix, AS; Fuhrman, BJ; Gass, ML; Kuller, LH; Pfeiffer, RM; Rohan, TE; Strickler, HD; Trabert, B; Wentzensen, N; Xu, X, 2016) |
| "To characterize model cell lines of endometrial cancer, we determined the expression profiles of the estrogen receptors (ERs) ESR1, ESR2 and GPER, and 23 estrogen biosynthetic and metabolic genes, and investigated estrogen biosynthesis in the control HIEEC cell line and the Ishikawa and HEC-1A EC cell lines." | 1.42 | The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism. ( Hevir-Kene, N; Rižner, TL, 2015) |
| "Type 1 endometrial cancer (EC) is typically sex hormone sensitive; however, most women diagnosed with EC have already gone through menopause." | 1.40 | Postmenopausal patients with endometrial cancer of type 1 have elevated serum estradiol levels in the ovarian vein. ( Ashihara, K; Maruoka, R; Ohmichi, M; Ono, YJ; Tanabe, A; Tanaka, T; Terai, Y, 2014) |
| "The associations with endometrial cancer were examined using conditional logistic regression to estimate odds ratio and 95% confidence intervals adjusted for known risk factors." | 1.37 | Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk. ( Buring, J; De Vivo, I; Karageorgi, S; Kraft, P; Lee, IM; McGrath, M, 2011) |
| "Using conditional regression analysis, endometrial cancer risk among postmenopausal women was positively associated with increasing levels of total testosterone, free testosterone, estrone, total estradiol, and free estradiol." | 1.35 | Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). ( Allen, NE; Ardanaz, E; Berrino, F; Bingham, S; Boeing, H; Boutron-Ruault, MC; Bueno-de-Mesquita, HB; Chang-Claude, J; Clavel-Chapelon, F; Cust, A; Dossus, L; Kaaks, R; Key, TJ; Khaw, KT; Lahmann, PH; Larrañaga, N; Linseisen, J; Lukanova, A; Lundin, E; Naska, A; Olsen, A; Onland-Moret, NC; Overvad, K; Palli, D; Panico, S; Peeters, PH; Pera, G; Ramón Quirós, J; Riboli, E; Rinaldi, S; Sánchez, MJ; Schulz, M; Tjønneland, A; Tormo, MJ; Trichopoulos, D; Trichopoulou, A; Tumino, R, 2008) |
| "Among women with endometrial carcinoma, larger ovaries were associated with higher serum levels of estrogens." | 1.34 | Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones. ( Brinton, LA; Carreon, JD; Garcia-Closas, M; Hartge, P; Lacey, JV; Madigan, MP; Potischman, N; Sherman, ME, 2007) |
| "In all, 10 RCCs were associated with breast carcinoma; 4, with endometrial carcinoma; and 3, with ovarian carcinoma." | 1.30 | Multiple primary tumors: 17 cases of renal-cell carcinoma associated with primary tumors involving different steroid-hormone target tissues. ( De Vico, A; Di Silverio, F; Flammia, GP; Mariani, M; Sciarra, A, 1997) |
| "Identified risk factors for endometrial cancer are accepted as operating through estrogen exposure." | 1.30 | Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones. ( Gail, MH; Hoover, RN; Potischman, N; Troisi, R; Wacholder, S, 1999) |
| "The estrone concentration was estimated in tissue of endometrial cancer and in the serum of 103 postmenopausal women." | 1.29 | [Estrone concentration in endometrial cancer tissue in relation to body mass]. ( Kotarski, J, 1994) |
| "However, the binding capacity in the endometrial carcinoma increased to 1." | 1.29 | Possible evidence for estrone-specific binding sites in human uterine endometrial carcinoma. ( Imai, A; Misao, R; Tamaya, T; Wada, K, 1994) |
| "Fifty postmenopausal patients with endometrial cancer and 54 matching controls." | 1.29 | Plasma oestrogens in postmenopausal women with endometrial cancer. ( Dreisler, A; Hagen, C; Haug, E; Lyndrup, J; Nielsen, AL; Nyholm, HC, 1993) |
| "Human endometrial cancer cells and human endometrial tissue have been extensively used to study steroid hormone action and metabolism." | 1.29 | Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro. ( Back, DJ; Rudland, PS; Wild, MJ, 1993) |
| "High estrone levels were associated with increased risk (OR = 3." | 1.29 | Case-control study of endogenous steroid hormones and endometrial cancer. ( Barrett, RJ; Berman, ML; Brinton, LA; Dorgan, JF; Hoover, RN; Lurain, JR; Mortel, R; Persky, V; Potischman, N; Siiteri, P; Swanson, CA; Twiggs, LB; Wilbanks, GD, 1996) |
| "Estrone sulfate (E1-S) has been shown to be quantitatively the most important estrogen in peripheral blood." | 1.28 | [Tissue culture and estrogen, to clarify the roles of estrone sulfate]. ( Honjo, H; Kitawaki, J; Naitoh, K; Ogino, Y; Okada, H; Urabe, M; Yamamoto, T; Yasuda, J, 1989) |
| "94 patients with endometrial cancer and double that number of matched controls were examined." | 1.26 | Doubts about oestrogen therapy in postmenopausal women. ( , 1976) |
| "By 1945, endometrial cancer had been identified by vaginal smear and verified by biopsy." | 1.23 | Cancer of endometrium and prolonged estrogen therapy. ( Fremont-smith, M; Gilbert, HH; Graham, RM; Meigs, JV, 1946) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (11.90) | 18.7374 |
| 1990's | 12 (28.57) | 18.2507 |
| 2000's | 10 (23.81) | 29.6817 |
| 2010's | 10 (23.81) | 24.3611 |
| 2020's | 5 (11.90) | 2.80 |
| Authors | Studies |
|---|---|
| Zeleniuch-Jacquotte, A | 1 |
| Shore, RE | 1 |
| Afanasyeva, Y | 1 |
| Lukanova, A | 2 |
| Sieri, S | 1 |
| Koenig, KL | 1 |
| Idahl, A | 1 |
| Krogh, V | 1 |
| Liu, M | 1 |
| Ohlson, N | 1 |
| Muti, P | 1 |
| Arslan, AA | 1 |
| Lenner, P | 1 |
| Berrino, F | 2 |
| Hallmans, G | 1 |
| Toniolo, P | 1 |
| Lundin, E | 2 |
| Slomovitz, BM | 1 |
| Filiaci, VL | 1 |
| Walker, JL | 1 |
| Taub, MC | 1 |
| Finkelstein, KA | 1 |
| Moroney, JW | 1 |
| Fleury, AC | 1 |
| Muller, CY | 1 |
| Holman, LL | 1 |
| Copeland, LJ | 1 |
| Miller, DS | 1 |
| Coleman, RL | 1 |
| Zottel, A | 1 |
| Jójárt, R | 1 |
| Ágoston, H | 1 |
| Hafner, E | 1 |
| Lipušček, N | 1 |
| Mernyák, E | 1 |
| Rižner, TL | 3 |
| Forsse, D | 1 |
| Tangen, IL | 1 |
| Fasmer, KE | 1 |
| Halle, MK | 1 |
| Viste, K | 1 |
| Almås, B | 1 |
| Bertelsen, BE | 1 |
| Trovik, J | 1 |
| Haldorsen, IS | 1 |
| Krakstad, C | 2 |
| Xanthoulea, S | 2 |
| Konings, GFJ | 1 |
| Saarinen, N | 1 |
| Delvoux, B | 3 |
| Kooreman, LFS | 1 |
| Koskimies, P | 2 |
| Häkkinen, MR | 1 |
| Auriola, S | 1 |
| D'Avanzo, E | 1 |
| Walid, Y | 1 |
| Verhaegen, F | 1 |
| Lieuwes, NG | 1 |
| Caiment, F | 1 |
| Kruitwagen, R | 1 |
| Romano, A | 3 |
| Pavlič, R | 1 |
| Vidic, S | 1 |
| Anko, M | 1 |
| Knific, T | 1 |
| Büdefeld, T | 1 |
| Marton, K | 1 |
| Sinreih, M | 1 |
| Poschner, S | 1 |
| Jäger, W | 1 |
| Frković-Grazio, S | 1 |
| Konings, GF | 1 |
| Cornel, KM | 2 |
| Skowron, MA | 1 |
| Kooreman, L | 1 |
| Salvesen, HB | 1 |
| van Kuijk, K | 1 |
| Schrooders, YJ | 1 |
| Vooijs, M | 1 |
| Groot, AJ | 1 |
| Bongers, MY | 1 |
| Kruitwagen, RF | 2 |
| Tian, W | 1 |
| Teng, F | 1 |
| Zhao, J | 1 |
| Gao, J | 1 |
| Gao, C | 1 |
| Sun, D | 1 |
| Liu, G | 1 |
| Zhang, Y | 1 |
| Yu, S | 1 |
| Zhang, W | 1 |
| Wang, Y | 1 |
| Xue, F | 1 |
| Playdon, MC | 1 |
| Coburn, SB | 1 |
| Moore, SC | 1 |
| Brinton, LA | 4 |
| Wentzensen, N | 2 |
| Anderson, G | 1 |
| Wallace, R | 1 |
| Falk, RT | 2 |
| Pfeiffer, R | 1 |
| Xu, X | 2 |
| Trabert, B | 2 |
| Ashihara, K | 1 |
| Tanaka, T | 2 |
| Maruoka, R | 1 |
| Ono, YJ | 1 |
| Tanabe, A | 1 |
| Terai, Y | 1 |
| Ohmichi, M | 1 |
| Hevir-Kene, N | 1 |
| Anderson, GL | 1 |
| Felix, AS | 1 |
| Fuhrman, BJ | 1 |
| Gass, ML | 1 |
| Kuller, LH | 1 |
| Pfeiffer, RM | 1 |
| Rohan, TE | 1 |
| Strickler, HD | 1 |
| Allen, NE | 1 |
| Key, TJ | 1 |
| Dossus, L | 1 |
| Rinaldi, S | 1 |
| Cust, A | 1 |
| Peeters, PH | 1 |
| Onland-Moret, NC | 1 |
| Lahmann, PH | 1 |
| Panico, S | 1 |
| Larrañaga, N | 1 |
| Pera, G | 1 |
| Tormo, MJ | 1 |
| Sánchez, MJ | 1 |
| Ramón Quirós, J | 1 |
| Ardanaz, E | 1 |
| Tjønneland, A | 1 |
| Olsen, A | 1 |
| Chang-Claude, J | 1 |
| Linseisen, J | 1 |
| Schulz, M | 1 |
| Boeing, H | 1 |
| Palli, D | 1 |
| Overvad, K | 1 |
| Clavel-Chapelon, F | 1 |
| Boutron-Ruault, MC | 1 |
| Bingham, S | 1 |
| Khaw, KT | 1 |
| Bueno-de-Mesquita, HB | 1 |
| Trichopoulou, A | 1 |
| Trichopoulos, D | 1 |
| Naska, A | 1 |
| Tumino, R | 1 |
| Riboli, E | 1 |
| Kaaks, R | 1 |
| Fournier, MA | 1 |
| Poirier, D | 1 |
| STOKES, EM | 1 |
| Bochkareva, NV | 2 |
| Kolomiets, LA | 2 |
| Kondakova, IV | 2 |
| Stukanov, SL | 1 |
| Tropina, TV | 1 |
| Muntian, AB | 1 |
| Westin, SN | 1 |
| Broaddus, RR | 2 |
| Deng, L | 2 |
| McCampbell, A | 2 |
| Lu, KH | 1 |
| Lacour, RA | 1 |
| Milam, MR | 1 |
| Urbauer, DL | 1 |
| Mueller, P | 1 |
| Pickar, JH | 2 |
| Loose, DS | 2 |
| Terry, K | 1 |
| McGrath, M | 2 |
| Lee, IM | 2 |
| Buring, J | 2 |
| De Vivo, I | 3 |
| Karageorgi, S | 1 |
| Kraft, P | 1 |
| Visconti, L | 1 |
| Van de Vijver, KK | 1 |
| Day, JM | 1 |
| Van Gorp, T | 1 |
| Hermans, RJ | 1 |
| Dunselman, GA | 1 |
| Fremont-smith, M | 1 |
| Meigs, JV | 1 |
| Graham, RM | 1 |
| Gilbert, HH | 1 |
| Silva, EG | 1 |
| Deavers, MT | 1 |
| Parlow, AF | 1 |
| Gershenson, DM | 1 |
| Malpica, A | 1 |
| TWOMBLY, GH | 1 |
| SCHEINER, S | 1 |
| LEVITZ, M | 1 |
| Paynter, RA | 1 |
| Hankinson, SE | 1 |
| Colditz, GA | 1 |
| Hunter, DJ | 1 |
| Shipley, GL | 1 |
| Stancel, GM | 1 |
| Davies, PJ | 1 |
| Pfeiffer, E | 1 |
| Graf, E | 1 |
| Gerstner, S | 1 |
| Metzler, M | 1 |
| Muntyan, AB | 1 |
| Shevchenko, VP | 1 |
| Nagaev, IY | 1 |
| Shevchenko, KV | 1 |
| Myasoedov, NF | 1 |
| Dorofeeva, NN | 1 |
| Sherman, ME | 1 |
| Madigan, MP | 1 |
| Lacey, JV | 1 |
| Garcia-Closas, M | 1 |
| Potischman, N | 3 |
| Carreon, JD | 1 |
| Hartge, P | 1 |
| Kotarski, J | 1 |
| Misao, R | 1 |
| Imai, A | 1 |
| Wada, K | 1 |
| Tamaya, T | 2 |
| Söderqvist, G | 1 |
| Olsson, H | 1 |
| Wilking, N | 1 |
| von Schoultz, B | 1 |
| Carlström, K | 1 |
| Nyholm, HC | 1 |
| Nielsen, AL | 1 |
| Lyndrup, J | 1 |
| Dreisler, A | 1 |
| Hagen, C | 1 |
| Haug, E | 1 |
| Niwa, K | 1 |
| Murase, T | 1 |
| Furui, T | 1 |
| Morishita, S | 1 |
| Mori, H | 2 |
| Wild, MJ | 1 |
| Rudland, PS | 1 |
| Back, DJ | 1 |
| Falany, JL | 1 |
| Falany, CN | 1 |
| Hoover, RN | 2 |
| Siiteri, P | 1 |
| Dorgan, JF | 1 |
| Swanson, CA | 1 |
| Berman, ML | 1 |
| Mortel, R | 1 |
| Twiggs, LB | 1 |
| Barrett, RJ | 1 |
| Wilbanks, GD | 1 |
| Persky, V | 1 |
| Lurain, JR | 1 |
| Castagnetta, LA | 1 |
| Granata, OM | 1 |
| Taibi, G | 1 |
| Lo Casto, M | 1 |
| Comito, L | 1 |
| Oliveri, G | 1 |
| Di Falco, M | 1 |
| Carruba, G | 1 |
| Di Silverio, F | 1 |
| Sciarra, A | 1 |
| Flammia, GP | 1 |
| Mariani, M | 1 |
| De Vico, A | 1 |
| Chetrite, G | 1 |
| Pasqualini, JR | 1 |
| Gail, MH | 1 |
| Troisi, R | 1 |
| Wacholder, S | 1 |
| Honjo, H | 1 |
| Urabe, M | 1 |
| Naitoh, K | 1 |
| Ogino, Y | 1 |
| Kitawaki, J | 1 |
| Yasuda, J | 1 |
| Yamamoto, T | 1 |
| Okada, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer[NCT03621904] | 150 participants (Anticipated) | Observational [Patient Registry] | 2022-10-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for estrone and Cancer of Endometrium
| Article | Year |
|---|---|
A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Endometrial Neoplasms; Estradiol; | 2022 |
Identification of a novel estrogen-regulated gene, EIG121, induced by hormone replacement therapy and differentially expressed in type I and type II endometrial cancer.
Topics: Adenocarcinoma; Biomarkers, Tumor; Case-Control Studies; Endometrial Hyperplasia; Endometrial Neopla | 2005 |
40 other studies available for estrone and Cancer of Endometrium
| Article | Year |
|---|---|
Postmenopausal circulating levels of 2- and 16α-hydroxyestrone and risk of endometrial cancer.
Topics: Aged; Case-Control Studies; Endometrial Neoplasms; Estrogens; Female; Humans; Hydroxyestrones; Middl | 2011 |
Cytotoxic effect of 13α-estrane derivatives on breast, endometrial and ovarian cancer cell lines.
Topics: Antineoplastic Agents; Cell Line, Tumor; Endometrial Neoplasms; Estrogens; Estrone; Female; Humans; | 2023 |
Blood steroid levels predict survival in endometrial cancer and reflect tumor estrogen signaling.
Topics: 17-alpha-Hydroxyprogesterone; Androstenedione; Biomarkers, Tumor; Carcinoma, Endometrioid; Chromatog | 2020 |
Pharmacological inhibition of 17β-hydroxysteroid dehydrogenase impairs human endometrial cancer growth in an orthotopic xenograft mouse model.
Topics: Animals; Antineoplastic Agents, Hormonal; Cell Growth Processes; Cell Line, Tumor; Endometrial Neopl | 2021 |
Altered Profile of E1-S Transporters in Endometrial Cancer: Lower Protein Levels of ABCG2 and OSTβ and Up-Regulation of
Topics: Age Factors; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Cell Lin | 2021 |
Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chick | 2018 |
Estrogen and insulin synergistically promote type 1 endometrial cancer progression.
Topics: Aged; Apoptosis; Carcinogenesis; Cell Cycle; Cell Proliferation; Endometrial Neoplasms; Endometrium; | 2017 |
Alcohol and oestrogen metabolites in postmenopausal women in the Women's Health Initiative Observational Study.
Topics: Aged; Alcohol Drinking; Case-Control Studies; Cross-Sectional Studies; Endometrial Neoplasms; Estrad | 2018 |
Postmenopausal patients with endometrial cancer of type 1 have elevated serum estradiol levels in the ovarian vein.
Topics: Aged; Carcinoma, Endometrioid; Endometrial Neoplasms; Estradiol; Estrone; Female; Humans; Hyperplasi | 2014 |
The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
Topics: 3-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Androstenedione; Aromatase; | 2015 |
Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
Topics: Aged; Biomarkers, Tumor; Carcinogenesis; Case-Control Studies; Endometrial Neoplasms; Estradiol; Est | 2016 |
Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
Topics: Adult; Aged; Androstenedione; Body Mass Index; Dehydroepiandrosterone Sulfate; Endometrial Neoplasms | 2008 |
Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).
Topics: 17-Hydroxysteroid Dehydrogenases; Aromatase; Cell Line, Tumor; Endometrial Neoplasms; Estradiol; Est | 2009 |
The association of estrogenic administration and adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Endometrial Neoplasms; Endometrium; Estrone; Female; Humans | 1948 |
[Sex hormones in the systemic and local circulation in endometrial hyperplasia and neoplasia: correlation with the activity of estrogen-metabolizing enzymes].
Topics: Androstenedione; Aromatase; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estrone; Fema | 2008 |
Molecular clustering of endometrial carcinoma based on estrogen-induced gene expression.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Biomarkers, Tumor; Body Mass Index; Carcinoma, Endometr | 2009 |
Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk.
Topics: Adult; Alleles; Case-Control Studies; Cholesterol Side-Chain Cleavage Enzyme; Endometrial Neoplasms; | 2010 |
Polymorphisms in genes hydroxysteroid-dehydrogenase-17b type 2 and type 4 and endometrial cancer risk.
Topics: 17-Hydroxysteroid Dehydrogenases; Adult; Case-Control Studies; Endometrial Neoplasms; Estradiol; Est | 2011 |
Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
Topics: Aged; Aged, 80 and over; Cell Line, Tumor; Cell Proliferation; Endometrial Neoplasms; Endometrium; E | 2012 |
Doubts about oestrogen therapy in postmenopausal women.
Topics: Age Factors; Biology; Birth Rate; Contraception; Contraceptive Agents; Contraceptive Agents, Female; | 1976 |
Cancer of endometrium and prolonged estrogen therapy.
Topics: Amenorrhea; Biology; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptiv | 1946 |
Calcifications in ovary and endometrium and their neoplasms.
Topics: Animals; Calcinosis; Chorionic Gonadotropin; Clomiphene; Dihydrotestosterone; Endometrial Neoplasms; | 2003 |
Endometrial cancer, obesity, and estrogenic excretion in women.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estrogens; Estrone; Female; Humans; Obesity; Uterine Neoplasm | 1961 |
No evidence of a role for PPARgamma Pro12Ala polymorphism in endometrial cancer susceptibility.
Topics: Alanine; Alleles; Amino Acid Substitution; Androstenedione; Aromatase; Carcinoma; Case-Control Studi | 2004 |
Stimulation of estradiol glucuronidation: a protective mechanism against estradiol-mediated carcinogenesis?
Topics: Breast Neoplasms; Endometrial Neoplasms; Estradiol; Estrone; Female; Glucuronides; Humans; Isoflavon | 2006 |
Synthesis of highly tritium labeled steroids for evaluation of aromatase and steroidsulfatase activities in endometrial tumors.
Topics: Aromatase; Cell Differentiation; Endometrial Neoplasms; Estrone; Female; Humans; Isotope Labeling; M | 2006 |
Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones.
Topics: Aged; Androstenedione; Case-Control Studies; Endometrial Neoplasms; Estradiol; Estrone; Female; Gona | 2007 |
[Estrone concentration in endometrial cancer tissue in relation to body mass].
Topics: Aged; Aged, 80 and over; Body Mass Index; Endometrial Neoplasms; Estrone; Female; Humans; Middle Age | 1994 |
Possible evidence for estrone-specific binding sites in human uterine endometrial carcinoma.
Topics: Binding Sites; Cell Nucleus; Cytosol; Endometrial Neoplasms; Endometrium; Estrone; Female; Humans; K | 1994 |
Metabolism of estrone sulfate by normal breast tissue: influence of menopausal status and oral contraceptives.
Topics: Adolescent; Adult; Aged; Breast; Breast Neoplasms; Contraceptives, Oral; Endometrial Neoplasms; Estr | 1994 |
Plasma oestrogens in postmenopausal women with endometrial cancer.
Topics: Aged; Androstenedione; Body Mass Index; Dehydroepiandrosterone; Endometrial Neoplasms; Estradiol; Es | 1993 |
Enhancing effects of estrogens on endometrial carcinogenesis initiated by N-methyl-N-nitrosourea in ICR mice.
Topics: Adenocarcinoma; Animals; Endometrial Hyperplasia; Endometrial Neoplasms; Estradiol; Estriol; Estrone | 1993 |
Metabolism of the oral contraceptive steroids ethynylestradiol, norgestimate and 3-ketodesogestrel by a human endometrial cancer cell line (HEC-1A) and endometrial tissue in vitro.
Topics: Chromatography, High Pressure Liquid; Contraceptives, Oral, Hormonal; Desogestrel; Endometrial Neopl | 1993 |
Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone.
Topics: Adenocarcinoma; Endometrial Neoplasms; Estrone; Female; Humans; Mifepristone; Progesterone; RNA, Mes | 1996 |
Case-control study of endogenous steroid hormones and endometrial cancer.
Topics: Adult; Androstenedione; Case-Control Studies; Endometrial Neoplasms; Estradiol; Estrogens, Conjugate | 1996 |
17 beta-hydroxysteroid oxidoreductase activity in intact cells significantly differs from classical enzymology analysis.
Topics: 17-Hydroxysteroid Dehydrogenases; Animals; Breast Neoplasms; Endometrial Neoplasms; Estradiol; Estro | 1996 |
Multiple primary tumors: 17 cases of renal-cell carcinoma associated with primary tumors involving different steroid-hormone target tissues.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Renal Cell; Endometrial Neoplasms; Estradiol; Estrone; Fem | 1997 |
Steroid sulphotransferase and 17beta-hydroxysteroid dehydrogenase activities in Ishikawa human endometrial adenocarcinoma cells.
Topics: 17-Hydroxysteroid Dehydrogenases; Adenocarcinoma; Dehydroepiandrosterone; Endometrial Neoplasms; Est | 1997 |
Measurement error does not explain the persistence of a body mass index association with endometrial cancer after adjustment for endogenous hormones.
Topics: Bias; Body Mass Index; Calibration; Endometrial Neoplasms; Estrone; Female; Humans; Logistic Models; | 1999 |
[Tissue culture and estrogen, to clarify the roles of estrone sulfate].
Topics: Alzheimer Disease; Breast Neoplasms; Culture Techniques; Endometrial Neoplasms; Endometrium; Estradi | 1989 |